GE Aerospace (GE)
(Delayed Data from NYSE)
$187.08 USD
+3.19 (1.73%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $186.68 -0.40 (-0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$187.08 USD
+3.19 (1.73%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $186.68 -0.40 (-0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Zacks News
Top Research Reports for Disney, General Electric & Fiserv
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney (DIS), General Electric (GE) and Fiserv (FISV).
Join the Wall Street Rally With Industrial ETFs
by Sanghamitra Saha
The industrial sector contributed to the colossal rally at Wall Street on Mar 24 on the hopes of deal wins and a slew of good news from the space.
4 Stocks Bucking the Layoff Trend Amid Coronavirus Scare
by Suranjana Roy
COVID-19 is taking an enormous toll on economic and health infrastructure, thereby resulting in massive layoffs. However, there are certain companies that are challenging this downtrend.
General Electric Announces Coronavirus' Impacts on Its Business
by Zacks Equity Research
General Electric's (GE) aviation segment seeks to lower the U.S. workforce by 10% on coronavirus concerns. The company announces various other measures to deal with the impact of the outbreak.
Danaher to Soon Close BioPharma Buyout, Receives FTC Approval
by Zacks Equity Research
Danaher (DHR) receives a go-ahead for the acquisition of GE's BioPharma business. The buyout will likely strengthen its biologics workflow solutions business.
Yes, You Can Time the Market. Find out How - March 20, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
General Electric (GE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
General Electric (GE) closed the most recent trading day at $6.48, moving -1.82% from the previous trading session.
GE to Offer Wind Turbine Solution to Sanko Enerji in Turkey
by Zacks Equity Research
General Electric's (GE) Cypress wind turbines are likely to make Guney wind farm in Turkey efficient in producing clean energy and cater to the increasing demand for electricity.
Lockheed Martin (LMT) Wins Deal to Deliver 50 C-130J Parts
by Zacks Equity Research
Lockheed Martin (LMT) is going to deliver 14 enhanced center wing boxes and 14 component kits in relation to the C-130J center wing box replacement program.
Danaher (DHR) Poised to Gain From Buyouts Despite Cost Woes
by Zacks Equity Research
Danaher (DHR) to gain from synergistic benefits from acquired assets as well as innovation efforts and shareholder-friendly policies. High costs and debts along with forex woes might be dragging.
4 Investment-Worthy Industrial Stocks Amid Coronavirus Scare
by Payal Jalan
Impacts of the coronavirus outbreak are visible among the U.S. corporates and hence get reflected on the major stock indexes. Price declines have created good entry point for a few industrial stocks.
Wind Generation Exceeds Hydroelectric in 2019: Stocks in Focus
by Zacks Equity Research
Annual wind generation in the United States totals 300 million megawatt-hours (MWh) in 2019, exceeding hydroelectric generation by 26 million MWh.
The Truth About Market Timing - March 02, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Why Is GE (GE) Down 18.4% Since Last Earnings Report?
by Zacks Equity Research
GE (GE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
General Electric Unit Gets Wind Turbine Deal From EDF-SITAC
by Zacks Equity Research
General Electric's (GE) 2.7 MW wind turbines are likely to make Sitac Kabini wind farm more efficient in producing renewable energy in Gujarat, India.
Forget Virus Scare, Buy Tech ETFs on the Dip
by Sanghamitra Saha
Wall Street is suffering a bloodbath on rising coronavirus scare, with tech stocks leading the slump. Use the dip in tech ETFs as a buying point.
Here's Why Investors Should Bet on Emerson (EMR) Stock Now
by Zacks Equity Research
Favorable trends in most of Emerson's (EMR) process and hybrid end markets along with solid robust backlog level at the Automation Solutions segment are impressive.
The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony
Can Industrial ETFs Gain Post Mixed Q4 Earnings?
by Sweta Jaiswal, FRM
We discuss the impact of Q4 earnings releases of some major players on the industrial ETFs with heavy exposure to the same.
The Truth About Market Timing - February 07, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Top Stock Research Reports for Alphabet, Roche & Amgen
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Roche Holding (RHHBY) and Amgen (AMGN).
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for GSEW
What's in the Offing for Emerson (EMR) in Q1 Earnings?
by Zacks Equity Research
Emerson's (EMR) fiscal Q1 earnings are likely to have gained from steady demand in process and hybrid end markets. Weak global discrete manufacturing market might have been a concern.
Danaher (DHR) Surpasses Q4 Earnings and Sales Estimates
by Zacks Equity Research
Danaher's (DHR) fourth-quarter 2019 earnings benefit from sales growth and margin improvement. It expects to complete the BioPharma buyout in the first quarter of 2020.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge